J 2019

ColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal cancer

ESTEBAN-GIL, Angel; Fernando PEREZ-SANZ; Jose GARCIA-SOLANO; Begona ALBURQUERQUE-GONZALEZ; Maria PARRENO-GONZALEZ et. al.

Základní údaje

Originální název

ColPortal, an integrative multiomic platform for analysing epigenetic interactions in colorectal cancer

Autoři

ESTEBAN-GIL, Angel; Fernando PEREZ-SANZ; Jose GARCIA-SOLANO; Begona ALBURQUERQUE-GONZALEZ; Maria PARRENO-GONZALEZ; Maria del Carmen LEGAZ-GARCIA; Jesualdo Tomas FERNANDEZ-BREIS; Edith RODRIGUEZ-BRAUN; Paola PIMENTEL; Anne TUOMISTO; Markus MAKINEN; Ondřej SLABÝ a Pablo CONESA-ZAMORA

Vydání

SCIENTIFIC DATA, LONDON, NATURE PUBLISHING GROUP, 2019, 2052-4463

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 5.541

Kód RIV

RIV/00216224:14740/19:00112508

Organizační jednotka

Středoevropský technologický institut

UT WoS

000494480700001

EID Scopus

2-s2.0-85074370857

Klíčová slova anglicky

MICROSATELLITE INSTABILITY; PROMOTER HYPERMETHYLATION; SERRATED POLYPS; COLON-CANCER; PHENOTYPE; CARCINOGENESIS; ADENOCARCINOMA; BIOMARKERS; PATHWAYS; GENES

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 26. 2. 2020 12:38, Mgr. Pavla Foltynová, Ph.D.

Anotace

V originále

Colorectal cancer (CRC) is the third leading cause of cancer mortality worldwide. Different pathological pathways and molecular drivers have been described and some of the associated markers are used to select effective anti-neoplastic therapy. More recent evidence points to a causal role of microbiota and altered microRNA expression in CRC carcinogenesis, but their relationship with pathological drivers or molecular phenotypes is not clearly established. Joint analysis of clinical and omics data can help clarify such relations. We present ColPortal, a platform that integrates transcriptomic, microtranscriptomic, methylomic and microbiota data of patients with colorectal cancer. ColPortal also includes detailed information of histological features and digital histological slides from the study cases, since histology is a morphological manifestation of a complex molecular change. The current cohort consists of Caucasian patients from Europe. For each patient, demographic information, location, histology, tumor staging, tissue prognostic factors, molecular biomarker status and clinical outcomes are integrated with omics data. ColPortal allows one to perform multiomics analyses for groups of patients selected by their clinical data.